基于抗体的乳腺癌治疗方法:临床和转化视角
Anna Balata1, Katarzyna Pogoda1
1Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, 02781 Warsaw, Poland.
Antibodies (Basel, Switzerland)
|January 21, 2026
概括
基于抗体的疗法,包括单克隆抗体,抗体-药物联合体和双特异性抗体,正在为所有亚型的乳腺癌治疗带来革命性变化. 这些创新提供了个性化的策略,但需要管理耐药性和毒性,以获得最佳结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌是全球妇女死亡的主要原因.
- 最近基于抗体的治疗方法的进展显著改善了HER2阳性,三阴性和光线性乳腺癌亚型的结果.
- 已建立的疗法包括针对HER2的单克隆抗体和针对三阴性乳腺癌的免疫疗法.
研究的目的:
- 审查乳腺癌新型抗体治疗的生物学理由,临床证据,耐药性机制和安全性概况.
- 为了突出抗体-药物合物和双特异性抗体的不断扩大的作用.
- 讨论这些药物在个性化和免疫学知情治疗策略中的潜力.
主要方法:
- 临床试验和临床前研究的文献综述.
- 对单克隆抗体,双特异性抗体和抗体与药物合物的数据进行分析.
- 生物机制,临床疗效,耐药性模式和安全数据的总结.
主要成果:
- 单克隆抗体 (如特拉斯图祖马布,珀图祖马布) 是对HER2阳性乳腺癌的标准治疗.
- 免疫检查点抑制剂在三阴性乳腺癌中有效.
- 抗体-药物联结物 (例如,特拉斯图祖马布德鲁克斯坦,萨基图祖马布戈维特肯) 和双特异性抗体提供了新的治疗途径.
- 挑战包括治疗耐药性和管理毒性.
结论:
- 基于抗体的疗法正在改变乳腺癌护理,提供个性化和免疫学知情的方法.
- 持续的研究对于克服阻力机制和优化安全配置文件至关重要.
- 这些进展正在为乳腺癌患者重新定义精确瘤学.
相关概念视频
Changes in Skin Color: Clinical Perspectives
3.3K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.3K
Translation
155.7K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.7K
Initiation of Translation
38.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K
Termination of Translation
27.5K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.5K
Psychodynamic Perspectives on Personality
1.5K
The psychodynamic perspective in psychology asserts that most personality functions operate unconsciously, outside of awareness. This means that the motives and emotions driving behavior often remain hidden, automatically buried in the unconscious mind as a defense mechanism to shield us from psychological distress. According to this theory, the unconscious mind contains thoughts, memories, and emotions that are too disturbing to face directly.
Psychodynamic theorists argue that unconscious...
Psychodynamic theorists argue that unconscious...
1.5K


